Pimecrolimus and tacrolimus for atopic dermatitis
... bleeding, secondary infection and thickening of the skin (lichenification). ...
... bleeding, secondary infection and thickening of the skin (lichenification). ...
RNAO Peds. Asth.FINAL - Registered Nurses` Association of Ontario
... disseminates this nursing best practice guideline to you. Evidence-based practice supports the excellence in service that nurses are committed to deliver in our day-to-day practice. We offer our endless thanks to the many institutions and individuals that are making RNAO’s vision for Nursing Best Pr ...
... disseminates this nursing best practice guideline to you. Evidence-based practice supports the excellence in service that nurses are committed to deliver in our day-to-day practice. We offer our endless thanks to the many institutions and individuals that are making RNAO’s vision for Nursing Best Pr ...
2014 PQRS Individual Measure Spec Manual
... (HCPCS) codes specified in the measure that are submitted by individual eligible professionals as part of a claim for covered services under the PFS for claims-based reporting. This same criteria is also applied for individual eligible professsionals and group practices who chose to report via a reg ...
... (HCPCS) codes specified in the measure that are submitted by individual eligible professionals as part of a claim for covered services under the PFS for claims-based reporting. This same criteria is also applied for individual eligible professsionals and group practices who chose to report via a reg ...
ASTHMA CONTROL AND CLINICAL MANAGEMENT IN CHILDREN AND ADULTS, MICHIGAN, 2008‐2010
... According to national treatment guidelines, the overarching goal of therapy is to achieve asthma control, defined, in part, by no or few sleep disturbing asthma symptoms. – The prevalence of frequent sleep disturbing symptoms was significantly higher (3.2 times) among adults with a household inc ...
... According to national treatment guidelines, the overarching goal of therapy is to achieve asthma control, defined, in part, by no or few sleep disturbing asthma symptoms. – The prevalence of frequent sleep disturbing symptoms was significantly higher (3.2 times) among adults with a household inc ...
Guidelines for the diagnosis and management of syncope
... Disclaimer. The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, ...
... Disclaimer. The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, ...
1: Neurol Neurochir Pol - PIEL
... can underlie these reactions. Complex interactions between genetic, infectious and/or environmental factors probably contribute to the presence of these diseases. Autoimmune diseases affect 3-8% of the general population; women account for 78-85% of all patients with autoimmune diseases. Although mo ...
... can underlie these reactions. Complex interactions between genetic, infectious and/or environmental factors probably contribute to the presence of these diseases. Autoimmune diseases affect 3-8% of the general population; women account for 78-85% of all patients with autoimmune diseases. Although mo ...
BIBLIOGRAPHIE SUR LE DELIRIUM
... fracture patients aged >=65 years was used. The control group (n = 678) was enrolled between July 1996 and September 1997 before implementation of the pathway and the CP group (n = 663) was enrolled between July 1999 and September 2000 following pathway implementation. Chart reviews were completed d ...
... fracture patients aged >=65 years was used. The control group (n = 678) was enrolled between July 1996 and September 1997 before implementation of the pathway and the CP group (n = 663) was enrolled between July 1999 and September 2000 following pathway implementation. Chart reviews were completed d ...
Guidelines for the diagnosis and management of syncope (version 2009)
... Disclaimer. The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, ...
... Disclaimer. The ESC Guidelines represent the views of the ESC and were arrived at after careful consideration of the available evidence at the time they were written. Health professionals are encouraged to take them fully into account when exercising their clinical judgement. The guidelines do not, ...
A Review of the Use of the Number Needed to Treat to Evaluate the
... their interpretations. Thus, any comparison of NNT values must use the same controls for calculations; comparing NNT values calculated with different control groups would not be valid. Therefore, the discussions in this review are limited to comparisons to placebo controls, unless otherwise so state ...
... their interpretations. Thus, any comparison of NNT values must use the same controls for calculations; comparing NNT values calculated with different control groups would not be valid. Therefore, the discussions in this review are limited to comparisons to placebo controls, unless otherwise so state ...
ZITHROMAX (azithromycin tablets) and
... (bone, ejaculum, prostate, ovary, uterus, salpinx, stomach, liver, and gallbladder). As there are no data from adequate and well-controlled studies of azithromycin treatment of infections in these additional body sites, the clinical significance of these tissue concentration data is unknown. Followi ...
... (bone, ejaculum, prostate, ovary, uterus, salpinx, stomach, liver, and gallbladder). As there are no data from adequate and well-controlled studies of azithromycin treatment of infections in these additional body sites, the clinical significance of these tissue concentration data is unknown. Followi ...
product monograph
... (CNS) depressant effects. Depending on the route of administration and dose used, midazolam can produce sedative-hypnotic effects or induce anesthesia. The administration of midazolam may often be followed by anterograde amnesia. Onset of sedative effects after intramuscular administration is about ...
... (CNS) depressant effects. Depending on the route of administration and dose used, midazolam can produce sedative-hypnotic effects or induce anesthesia. The administration of midazolam may often be followed by anterograde amnesia. Onset of sedative effects after intramuscular administration is about ...
idarubicin
... be monitored throughout therapy to minimize the risk of incurring severe cardiac impairment. The risk may be decreased through regular monitoring of LVEF during the course of treatment with prompt discontinuation of idarubicin at the first sign of impaired function. The appropriate quantitative meth ...
... be monitored throughout therapy to minimize the risk of incurring severe cardiac impairment. The risk may be decreased through regular monitoring of LVEF during the course of treatment with prompt discontinuation of idarubicin at the first sign of impaired function. The appropriate quantitative meth ...
CANADA - CLG.ORG
... mg dual chamber syringe) for intra-muscular injection usually to be administered monthly; II. ...
... mg dual chamber syringe) for intra-muscular injection usually to be administered monthly; II. ...
Evaluation of Tremors
... Essential Tremor-Treatment Propranolol – beta-blocker • 30-320 mg per day, can use long acting preparations • One study found an average of approximately a 50% reduction in amplitude • Most common side effects: lightheadedness, fatigue, impotence, bradycardia • Caution in patients with heart failure ...
... Essential Tremor-Treatment Propranolol – beta-blocker • 30-320 mg per day, can use long acting preparations • One study found an average of approximately a 50% reduction in amplitude • Most common side effects: lightheadedness, fatigue, impotence, bradycardia • Caution in patients with heart failure ...
European Guideline on Chronic Pruritus
... pruritus has to be considered individually. There is still a significant lack of randomised controlled trials (RCT), that can be explained by the diversity and complexity of this symptom, multifactorial aetiologies of pruritus and the lack of well-defined outcome measures. To complicate matters, RCT ...
... pruritus has to be considered individually. There is still a significant lack of randomised controlled trials (RCT), that can be explained by the diversity and complexity of this symptom, multifactorial aetiologies of pruritus and the lack of well-defined outcome measures. To complicate matters, RCT ...
Anaphylaxis: Recent advances in assessment and treatment
... clonal mast cell disorders,51-54 are associated with an increased risk of severe, life-threatening, or fatal anaphylaxis. Some concurrent medications, including any CNS-active medication such as diphenhydramine, chlorpheniramine, and other first-generation H1-antihistamines, or any CNS-active chemic ...
... clonal mast cell disorders,51-54 are associated with an increased risk of severe, life-threatening, or fatal anaphylaxis. Some concurrent medications, including any CNS-active medication such as diphenhydramine, chlorpheniramine, and other first-generation H1-antihistamines, or any CNS-active chemic ...
European Guideline on Chronic Pruritus
... pruritus has to be considered individually. There is still a significant lack of randomised controlled trials (RCT), that can be explained by the diversity and complexity of this symptom, multifactorial aetiologies of pruritus and the lack of well-defined outcome measures. To complicate matters, RCT ...
... pruritus has to be considered individually. There is still a significant lack of randomised controlled trials (RCT), that can be explained by the diversity and complexity of this symptom, multifactorial aetiologies of pruritus and the lack of well-defined outcome measures. To complicate matters, RCT ...
product monograph
... or the addition of occlusive dressings. Other risk factors for increased systemic effects include increasing hydration of the stratum corneum, use on thin skin areas (such as the face), use on broken skin or conditions where the skin barrier may be impaired. If patients must be treated over large b ...
... or the addition of occlusive dressings. Other risk factors for increased systemic effects include increasing hydration of the stratum corneum, use on thin skin areas (such as the face), use on broken skin or conditions where the skin barrier may be impaired. If patients must be treated over large b ...
BTS guidelines for the management of spontaneous pneumothorax
... British Thoracic Society (BTS) published guidelines for the treatment of both in 1993.19 Several studies suggest that compliance with the 1993 guidelines, though improving, remains at only 20–40% among non-respiratory and A&E staff.20–22 Clinical guidelines have been shown to improve clinical practi ...
... British Thoracic Society (BTS) published guidelines for the treatment of both in 1993.19 Several studies suggest that compliance with the 1993 guidelines, though improving, remains at only 20–40% among non-respiratory and A&E staff.20–22 Clinical guidelines have been shown to improve clinical practi ...
Local copy
... British Thoracic Society (BTS) published guidelines for the treatment of both in 1993.19 Several studies suggest that compliance with the 1993 guidelines, though improving, remains at only 20–40% among non-respiratory and A&E staff.20–22 Clinical guidelines have been shown to improve clinical practi ...
... British Thoracic Society (BTS) published guidelines for the treatment of both in 1993.19 Several studies suggest that compliance with the 1993 guidelines, though improving, remains at only 20–40% among non-respiratory and A&E staff.20–22 Clinical guidelines have been shown to improve clinical practi ...
Fall 2016 Newsletter
... studies that have improved the care of children. He especially focused on understanding the disease from the perspective of the patient and learning how to capture clinically relevant information. In ITP for example, he led the way in capturing important outcomes like bleeding symptoms and changed p ...
... studies that have improved the care of children. He especially focused on understanding the disease from the perspective of the patient and learning how to capture clinically relevant information. In ITP for example, he led the way in capturing important outcomes like bleeding symptoms and changed p ...
- International Council of Ophthalmology
... Copyright© 2008 SEAGIG, Sydney. All right reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means – electronic, mechanical, photocopying, recording or otherwise – without the prior permission of SEAGIG. ...
... Copyright© 2008 SEAGIG, Sydney. All right reserved. No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form or by any means – electronic, mechanical, photocopying, recording or otherwise – without the prior permission of SEAGIG. ...
MICROMEDEX® Healthcare Series OXCARBAZEPINE
... compared to adults (Prod Info TRILEPTAL(R) oral tablets, oral suspension, 2005) a) Partial seizure, monotherapy 1) 4 to 16 year old, initiation of monotherapy, 8-10 mg/kg/day ORALLY divided doses; may increase dose by 5 mg/kg/day every 3 days to the recommended maintenance dose (Prod Info TRILEPTAL( ...
... compared to adults (Prod Info TRILEPTAL(R) oral tablets, oral suspension, 2005) a) Partial seizure, monotherapy 1) 4 to 16 year old, initiation of monotherapy, 8-10 mg/kg/day ORALLY divided doses; may increase dose by 5 mg/kg/day every 3 days to the recommended maintenance dose (Prod Info TRILEPTAL( ...
Appendix W - Missouri Hospital Association
... be used to assist in determining which patients will be in the CAH long enough for the surveyor to contact the patient during the course of the survey. Patient logs (ED, OB, OR, etc.) in conjunction with the patient list provided by the facility, provide a good source to use when selecting patients ...
... be used to assist in determining which patients will be in the CAH long enough for the surveyor to contact the patient during the course of the survey. Patient logs (ED, OB, OR, etc.) in conjunction with the patient list provided by the facility, provide a good source to use when selecting patients ...